Shield Therapeutics PLC Stock
Your prediction
Shield Therapeutics PLC Stock
Shield Therapeutics PLC took a tumble today and lost -€0.004 (-4.550%).
Pros and Cons of Shield Therapeutics PLC in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Shield Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | -4.550% | -2.890% | -17.647% | 121.053% | -20.000% | 26.316% | -76.796% |
| Pets At Home Group Ls 1 | -0.550% | -6.417% | -19.169% | -27.436% | -8.537% | -47.761% | -52.915% |
| Card Factory plc | 0.000% | -5.850% | -10.940% | -28.290% | -8.947% | -27.004% | -14.568% |
| Natural Grocers By Vit. Cot. | 0.920% | -0.901% | 3.774% | -36.782% | 2.804% | 113.592% | 65.414% |
News
What Is the "Achilles Shield" and How Is Lockheed Martin Involved? Here's What Investors Need to Know.
Greece's air-defense capabilities will soon be getting an upgrade. That's the chief takeaway from the country's recent vote by the Special Permanent Parliamentary Committee on Armaments Programs and
5 Stocks and ETFs to Help Shield Your Portfolio During Volatility
The U.S. stock market has gotten off to an unsteady start this year. Outside a handful of defensive pockets, such as consumer staples and energy, most investors have felt the pressure. Elevated
Why Guardant Health Stock Surged Today
Shares of Guardant Health (NASDAQ: GH) rocketed 28% higher on Thursday after the precision oncology company reported outstanding growth metrics across its key product lines.
Image source: Getty